Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XL999 in relapsed or refractory multiple myeloma
NCT00304590Phase 2Terminated
- Sponsor
- Symphony Evolution
- Start
- Feb 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of xl999 in multiple myeloma (MM), sponsored by Symphony Evolution. Started Feb 2006; status: terminated.
02
Drugs
xl999
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00304590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304590.